Evidence map›Paper›PMID 28248254›Full record

ArticleProteomes2017

Partial Immunoblotting of 2D-Gels: A Novel Method to Identify Post-Translationally Modified Proteins Exemplified for the Myelin Acetylome.

Kathrin Kusch, Marina Uecker, Thomas Liepold, Wiebke Möbius, Christian Hoffmann, Heinz Neumann, Hauke B Werner, Olaf Jahn

Open access · goldAbstract read
In one paragraph

Article in Proteomes, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 28 citations in OpenAlex.

  1. International journal of molecular sciences · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Kathrin KuschDepartment of Neurogenetics, Max-Planck-Institute of Experimental Medicine, 37075 Göttingen, Germany. kusch@em.mpg.de.
Marina UeckerProteomics Group, Max-Planck-Institute of Experimental Medicine, 37075 Göttingen, Germany. uecker@em.mpg.de.
Thomas LiepoldProteomics Group, Max-Planck-Institute of Experimental Medicine, 37075 Göttingen, Germany. liepold@em.mpg.de.
Wiebke MöbiusDepartment of Neurogenetics, Max-Planck-Institute of Experimental Medicine, 37075 Göttingen, Germany. moebius@em.mpg.de.
Christian HoffmannFree Floater (Junior) Research Group Applied Synthetic Biology, Georg-August University Göttingen, Institute for Microbiology and Genetics, 37077 Göttingen, Germany. cho@accurion.com.
Heinz NeumannFree Floater (Junior) Research Group Applied Synthetic Biology, Georg-August University Göttingen, Institute for Microbiology and Genetics, 37077 Göttingen, Germany. heinz.neumann@mpi-dortmund.mpg.de.
Hauke B WernerDepartment of Neurogenetics, Max-Planck-Institute of Experimental Medicine, 37075 Göttingen, Germany. hauke@em.mpg.de.
Olaf JahnProteomics Group, Max-Planck-Institute of Experimental Medicine, 37075 Göttingen, Germany. jahn@em.mpg.de.
Max Planck Institute of Experimental Medicine · DENanoscale Microscopy and Molecular Physiology of the Brain Cluster of Excellence 171 — DFG Research Center 103 · DEUniversity of Göttingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Post-translational modifications (PTMs) play a key role in regulating protein function, yet their identification is technically demanding. Here, we present a straightforward workflow to systematically identify post-translationally modified proteins based on two-dimensional gel electrophoresis. Upon colloidal Coomassie staining the proteins are partially transferred, and the investigated PTMs are immunodetected. This strategy allows tracking back the immunopositive antigens to the corresponding spots on the original gel, from which they are excised and mass spectrometrically identified. Candidate proteins are validated on the same membrane by immunodetection using a second fluorescence channel. We exemplify the power of partial immunoblotting with the identification of lysine-acetylated proteins in myelin, the oligodendroglial membrane that insulates neuronal axons. The excellent consistency of the detected fluorescence signals at all levels allows the differential comparison of PTMs across multiple conditions. Beyond PTM screening, our multi-level workflow can be readily adapted to clinical applications such as identifying auto-immune antigens or host-pathogen interactions.

Indexed as

2D gel electrophoresis (2DE) blotacetylomecryo immuno-electron microscopy (IEM)cyclic nucleotide phosphodiesterase (CNP)immunoblotimmunoproteomicsisoelectric focusing (IEF)myelinpost-translational modification (PTM)septin 8 (SEPT8)SERPAtubulin acetylation

Identifiers

PMID28248254
PMCPMC5372224
OpenAlexW2573561420

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.